Acetyl-L-Carnitine in the Treatment of Septic Shock

Completed · Phase 1/Phase 2

Conditions studied: Septic Shock

In brief

This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic shock requiring vasopressors.

Key facts

Study ID

NCT00592488

Run by

Vanderbilt University

People needed

13

Starts

2006-08-01

Expected to finish

2009-09-01

Last updated by the study team

2017-12-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• documented or presumed infection
• shock requiring vasopressors

You may not qualify if…

• dialysis
• hepatic failure
• seizures

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.